TransMedics Net Debt from 2010 to 2025

TMDX Stock

USD 69.05 0.21 0.31%

TransMedics Net Debt yearly trend continues to be fairly stable with very little volatility. Net Debt is likely to outpace its year average in 2025. Net Debt is the total debt of TransMedics Group minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds. View All Fundamentals

Net Debt

First Reported

2018-12-31

Previous Quarter

188.1 M

Current Value

122.3 M

Quarterly Volatility

85.4 M

Covid

Check TransMedics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among TransMedics' main balance sheet or income statement drivers, such as Interest Expense of 15.1 M, Selling General Administrative of 177 M or Operating Income of 39.4 M, as well as many indicators such as Price To Sales Ratio of 4.46, Dividend Yield of 0.0 or PTB Ratio of 9.52. TransMedics financial statements analysis is a perfect complement when working with TransMedics Valuation or Volatility modules.

Check out the analysis of TransMedics Correlation against competitors.

Latest TransMedics' Net Debt Growth Pattern

Below is the plot of the Net Debt of TransMedics Group over the last few years. It is the total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds. TransMedics' Net Debt historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in TransMedics' overall financial position and show how it may be relating to other accounts over time.

Net Debt

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Net Debt

Timeline

TransMedics Net Debt Regression Statistics

	Arithmetic Mean	14,528,828
	Geometric Mean	11,623,091
	Coefficient Of Variation	440.49
	Mean Deviation	41,023,846
	Median	(3,284,000)
	Standard Deviation	63,997,801
	Sample Variance	4095.7T
	Range	262M
	R-Value	0.42
	Mean Square Error	3612.9T
	R-Squared	0.18
	Significance	0.10
	Slope	5,650,389
	Total Sum of Squares	61435.8T

TransMedics Net Debt History

	2025	128.4 M
	2024	122.3 M
	2023	121.1 M
	2022	-133.6 M
	2021	-17 M
	2020	10.1 M
	2019	14.1 M

Other Fundumenentals of TransMedics Group

Net Debt To E B I T D A

TransMedics Net Debt component correlations

	Total Assets	Total Stockholder Equity	Net Tangible Assets	Retained Earnings	Accounts Payable	Long Term Debt	Short Term Investments	Total Liab	Total Current Assets	Common Stock	Property Plant Equipment	Net Receivables	Current Deferred Revenue	Net Debt	Long Term Debt Total	Capital Surpluse	Net Invested Capital	Short Long Term Debt	Net Working Capital	Short Term Debt	Deferred Long Term Liab	Capital Stock	Intangible Assets
Total Assets		0.8	0.82	-0.72	0.7	0.99	-0.45	0.96	0.99	0.68	0.91	0.99	0.97	0.74	0.61	0.8	0.97	-0.78	0.99	-0.12	-0.65	0.84	-0.74
Total Stockholder Equity	0.8		0.95	-0.77	0.48	0.73	-0.21	0.69	0.83	0.94	0.89	0.79	0.67	0.39	0.92	0.61	0.91	-0.59	0.86	0.36	-0.9	0.93	-0.56
Net Tangible Assets	0.82	0.95		-0.75	0.5	0.75	-0.14	0.71	0.86	0.89	0.9	0.79	0.69	0.38	0.81	0.57	0.89	-0.55	0.88	0.2	-0.93	0.96	-0.53
Retained Earnings	-0.72	-0.77	-0.75		-0.64	-0.65	0.06	-0.65	-0.77	-0.83	-0.81	-0.66	-0.61	-0.33	-0.79	-0.44	-0.79	0.44	-0.76	-0.28	0.79	-0.83	0.42
Accounts Payable	0.7	0.48	0.5	-0.64		0.75	-0.3	0.73	0.71	0.56	0.62	0.64	0.75	0.66	0.51	0.45	0.69	-0.28	0.69	0.0	-0.52	0.58	-0.24
Long Term Debt	0.99	0.73	0.75	-0.65	0.75		-0.48	0.98	0.97	0.62	0.85	0.97	0.99	0.82	0.56	0.78	0.94	-0.76	0.96	-0.14	-0.57	0.77	-0.72
Short Term Investments	-0.45	-0.21	-0.14	0.06	-0.3	-0.48		-0.52	-0.41	-0.1	-0.44	-0.5	-0.5	-0.24	-0.05	-0.38	-0.37	0.36	-0.42	0.5	-0.11	-0.25	0.35
Total Liab	0.96	0.69	0.71	-0.65	0.73	0.98	-0.52		0.94	0.58	0.84	0.95	0.97	0.8	0.52	0.76	0.92	-0.74	0.94	-0.17	-0.54	0.74	-0.71
Total Current Assets	0.99	0.83	0.86	-0.77	0.71	0.97	-0.41	0.94		0.74	0.93	0.96	0.95	0.68	0.66	0.73	0.98	-0.71	1.0	-0.09	-0.7	0.89	-0.68
Common Stock	0.68	0.94	0.89	-0.83	0.56	0.62	-0.1	0.58	0.74		0.82	0.64	0.56	0.27	0.97	0.44	0.82	-0.32	0.76	0.48	-0.94	0.92	-0.28
Property Plant Equipment	0.91	0.89	0.9	-0.81	0.62	0.85	-0.44	0.84	0.93	0.82		0.9	0.81	0.44	0.73	0.68	0.94	-0.66	0.94	0.0	-0.77	0.95	-0.63
Net Receivables	0.99	0.79	0.79	-0.66	0.64	0.97	-0.5	0.95	0.96	0.64	0.9		0.94	0.73	0.58	0.87	0.95	-0.85	0.96	-0.14	-0.59	0.81	-0.81
Current Deferred Revenue	0.97	0.67	0.69	-0.61	0.75	0.99	-0.5	0.97	0.95	0.56	0.81	0.94		0.85	0.5	0.73	0.91	-0.71	0.94	-0.19	-0.5	0.72	-0.68
Net Debt	0.74	0.39	0.38	-0.33	0.66	0.82	-0.24	0.8	0.68	0.27	0.44	0.73	0.85		0.3	0.66	0.67	-0.64	0.66	-0.06	-0.26	0.34	-0.61
Long Term Debt Total	0.61	0.92	0.81	-0.79	0.51	0.56	-0.05	0.52	0.66	0.97	0.73	0.58	0.5	0.3		0.43	0.78	-0.34	0.68	0.64	-0.89	0.82	-0.31
Capital Surpluse	0.8	0.61	0.57	-0.44	0.45	0.78	-0.38	0.76	0.73	0.44	0.68	0.87	0.73	0.66	0.43		0.75	-0.85	0.72	-0.11	-0.42	0.6	-0.78
Net Invested Capital	0.97	0.91	0.89	-0.79	0.69	0.94	-0.37	0.92	0.98	0.82	0.94	0.95	0.91	0.67	0.78	0.75		-0.73	0.98	0.1	-0.77	0.9	-0.69
Short Long Term Debt	-0.78	-0.59	-0.55	0.44	-0.28	-0.76	0.36	-0.74	-0.71	-0.32	-0.66	-0.85	-0.71	-0.64	-0.34	-0.85	-0.73		-0.7	0.11	0.33	-0.49	0.99
Net Working Capital	0.99	0.86	0.88	-0.76	0.69	0.96	-0.42	0.94	1.0	0.76	0.94	0.96	0.94	0.66	0.68	0.72	0.98	-0.7		-0.06	-0.73	0.9	-0.67
Short Term Debt	-0.12	0.36	0.2	-0.28	0.0	-0.14	0.5	-0.17	-0.09	0.48	0.0	-0.14	-0.19	-0.06	0.64	-0.11	0.1	0.11	-0.06		-0.47	0.13	0.1
Deferred Long Term Liab	-0.65	-0.9	-0.93	0.79	-0.52	-0.57	-0.11	-0.54	-0.7	-0.94	-0.77	-0.59	-0.5	-0.26	-0.89	-0.42	-0.77	0.33	-0.73	-0.47		-0.89	0.3
Capital Stock	0.84	0.93	0.96	-0.83	0.58	0.77	-0.25	0.74	0.89	0.92	0.95	0.81	0.72	0.34	0.82	0.6	0.9	-0.49	0.9	0.13	-0.89		-0.45
Intangible Assets	-0.74	-0.56	-0.53	0.42	-0.24	-0.72	0.35	-0.71	-0.68	-0.28	-0.63	-0.81	-0.68	-0.61	-0.31	-0.78	-0.69	0.99	-0.67	0.1	0.3	-0.45

Click cells to compare fundamentals

About TransMedics Financial Statements

TransMedics investors use historical fundamental indicators, such as TransMedics' Net Debt, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in TransMedics. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Net Debt	122.3 M	128.4 M
Net Debt To EBITDA	1.75	1.84

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

V	Visa Class A
S	SentinelOne
GM	General Motors

Additional Tools for TransMedics Stock Analysis

When running TransMedics' price analysis, check to measure TransMedics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy TransMedics is operating at the current time. Most of TransMedics' value examination focuses on studying past and present price action to predict the probability of TransMedics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move TransMedics' price. Additionally, you may evaluate how the addition of TransMedics to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

TransMedics Net Debt from 2010 to 2025

Latest TransMedics' Net Debt Growth Pattern

TransMedics Net Debt Regression Statistics

TransMedics Net Debt History

Other Fundumenentals of TransMedics Group

TransMedics Net Debt component correlations

About TransMedics Financial Statements

Also Currently Popular

Additional Tools for TransMedics Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY